MolNFT v1 · #32745 · protein
Crystal structure of the human PIM1 in complex with a ruthenium organometallic ligand RU1
2BZH · Proto-oncogene serine threonine protein kinase PIM1: “Crystal structure of the human PIM1 in complex with a ruthenium organometallic ligand RU1”. X-ray diffraction, 2 ligands (HB1, CL), 1 pocket (best druggability 0.69). MolNFT v1…
- PDB
- 2BZH
- Type
- protein
- Length
- 275 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Proto-oncogene serine threonine protein kinase PIM1
- EC
- 2.7.1.37
- UniProt
- P11309
- Ligands
- HB1, CL
- Pockets
- 1 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 39% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| B | Proto-oncogene serine threonine protein kinase PIM1 (EC 2.7.1.37) | protein | 275 | 39% helix, 23% strand | P11309 |
Ligands and binding sites
- HB1 · Ruthenium-pyridocarbazole-1 · ligand · chains B
- CL · Chloride ion · ion · chains B
- EDO · 1,2-ethanediol · additive · chains B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 348 | 0.69 | 0.82 | 43 | HB1 |
Compared structures
- 2BZH · Crystal structure of the human PIM1 in complex with a ruthenium organometallic ligand RU1 · the same entry in another collection · chain B against B, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P11309
- Elsewhere: RCSB PDB 2BZH · PDBe 2BZH · UniProt P11309
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.